Riskpilot← Back to searchSign inGet full accessCATALYSTS TECHNOLOGIES AS
ASActiveOrg 913370163Tuengen Allé 20B, 0374 OsloBusiness and other management consultancy activities · NACE 7020Est. 20141 employees
Revenue 2024
NOK 1,3M
-43% vs 2023
EBITDA margin
-19.5%
-132% vs 2023
Equity ratio
70.1%
Financial strength
Net profit 2024
NOK -246K
-130% vs 2023
| Revenue | NOK 1,3M | -43% |
| EBITDA | NOK -259K | -132% |
| Net profit | NOK -246K | -130% |
| Total assets | NOK 1,6M | -33% |
| Equity | NOK 1,2M | -18% |
| Employees | 1 | — |
Legal name
CATALYSTS TECHNOLOGIES AS
Org number
913370163
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
14. mars 2014
Share capital
NOK 32 773
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å utvikling og kommersialisering av verktøy, metoder og digitale plattformer for psykososial oppfølging av ulike målgrupper, inkludert rådgivning og kursvirksomhet samt alt som hører naturlig til dette.
Address
Tuengen Allé 20B, 0374 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 919 | 1 124 | 634 | 842 | 1 041 | 2 081 | 1 402 | 1 089 | 1 594 | 2 311 | 1 326 |
| Staff expenses | −222 | −836 | −320 | −243 | −678 | −1 345 | −1 185 | −556 | −600 | −666 | −957 |
| EBITDA | 103 | −139 | −39 | 91 | −22 | −219 | −689 | −91 | 89 | 813 | −259 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 103 | −139 | −39 | 91 | −22 | −219 | −689 | −91 | 89 | 813 | −259 |
| Net financials | −1 | −5 | −17 | −0 | 0 | −3 | −16 | −1 | 0 | −0 | 13 |
| Profit before tax | 102 | −144 | −55 | 91 | −21 | −222 | −705 | −92 | 89 | 812 | −246 |
| Tax | 26 | −36 | −12 | 69 | −0 | −0 | −162 | −67 | −0 | −0 | −0 |
| Net profit | 76 | −108 | −44 | 22 | −21 | −222 | −542 | −26 | 89 | 812 | −246 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 749 | 883 | 418 | 213 | 565 | 1 362 | 780 | 763 | 892 | 2 442 | 1 643 |
| Equity | 100 | −8 | −51 | −30 | −29 | 749 | 206 | 497 | 586 | 1 398 | 1 152 |
| Long-term debt | 0 | 0 | 0 | 0 | 300 | 300 | 315 | 0 | 0 | 0 | 0 |
| Short-term debt | 648 | 891 | 469 | 243 | 294 | 314 | 259 | 267 | 306 | 1 044 | 491 |
| Total debt | 648 | 891 | 469 | 243 | 594 | 614 | 574 | 267 | 306 | 1 044 | 491 |
EBITDA margin
-19.5%
This company
15.8%
Market median
-223% vs market
20142024
Equity ratio
70.1%
This company
38.2%
Market median
+84% vs market
20142024
Return on equity
-21.4%
This company
18.4%
Market median
-216% vs market
20142024
Net profit margin
-18.6%
This company
8.1%
Market median
-330% vs market
20142024
Asset turnover
0.81×
This company
1.12×
Market median
+28% vs market
20142024
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20142024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-03-12 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JE Deputy Member | Deputy Member | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Inven2 As | Company | 5.4% | 5.4% | 2022 |
Koj Invest As | Company | 1.1% | 1.1% | 2022 |
Lisa Cooper Holding As | Company | 1.1% | 1.1% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Universitetet I Oslo
CATALYSTS TECHNOLOGIES AS Board members of CATALYSTS TECHNOLOGIES AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jon Enok Seip | Deputy Member | 0 companies |
| Katharina Ringen Asting | Board of Directors | 0 companies |
| Kristin Omholt-Jensen | Board of Directors | 0 companies |
| Thomas Francis Anglero | Board of Directors | 0 companies |
| Lisa Ann Cooper | Chairman | 0 companies |
| Ida Melbye-Larsen | Board of Directors | 0 companies |